Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation

BACKGROUND: Glaucoma is the second leading cause of blindness in the world and is characterized by optic neuropathy and degeneration of retinal ganglion cells (RGCs). Our preliminary research found that acteoside can inhibit autophagy-induced apoptosis of RGCs via the phosphatidylinositol 3-kinase (...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, Xiaoting, Chen, Qianbo, Ma, Jia, Wang, Xuewei, Xia, Yuan, Wen, Xuewei, Cai, Bin, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011318/
https://www.ncbi.nlm.nih.gov/pubmed/35433984
http://dx.doi.org/10.21037/atm-22-136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011318/
https://www.ncbi.nlm.nih.gov/pubmed/35433984
http://dx.doi.org/10.21037/atm-22-136

Ejemplares similares